€0.85
(1.18%)
Create an alert
Stocks and Shares ISAOrion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Company Information
About this company
Key people
Liisa Hurme
President, Chief Executive Officer, Chairman of the Executive Management Board
Outi Vaarala
Executive Vice President - Innovative Medicines and Research and Development, Member of the Executive Management Board
Mikko Kemppainen
General Counsel, Member of the Executive Management Board, Company Secretary, Head - Corporate Functions
Jani Korhonen
Development Manager - Clinical Product Development, Employee Representative on the Executive Management Board
Kari Jussi Aho
Non-Executive Independent Director
Ari Lehtoranta
Non-Executive Independent Director
Karen Lykke Sorensen
Non-Executive Independent Director
Veli-Matti Mattila
Non-Executive Independent Chairman for the Board
Hilpi Rautelin
Non-Executive Independent Vice Chairman of the Board
Rene Lindell
Chief Financial Officer, Member of the Executive Management Board
Julia Irene Macharey
Executive Vice President - People and Culture and Communications, Member of the Executive Management Board
Satu Ahomaeki
Executive Vice President - Generics and Consumer Health, Member of the Executive Management Board
Pan Hao
Executive Vice President - Branded Products, Member of the Executive Management Board
Juhani Kankaanpaeae
Executive Vice President - Global Operations, Fermion, Member of the Executive Management Board
Niclas Lindstedt
Executive Vice President - Animal Health, Member of the Executive Management Board
Click to see more
Key facts
- Shares in issue109.61m
- EPICORNBV
- ISINFI0009014377
- LocationFinland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€10.20bn
- Employees4,029
- ExchangeHelsinki Stock Exchange
- IndexFinland-OMX-Helsinki-All-Share
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.